Trials / Completed
CompletedNCT04692506
Study Evaluating the Safety and Tolerability
A Double-blind, Randomised, Placebo-controlled, Parallel-group Study Evaluating the Safety and Tolerability of Bifidobacterium Longum DSM 32947 Administered to Healthy Volunteers for 28 Days.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- BioGaia AB · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The rationale for the current study is to initially evaluate the safety and tolerability of B. longum strain in healthy volunteers.
Detailed description
The design of the study is based on the aim to study safety and tolerability of B. longum in a limited number of healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Probiotic | The study product is probiotic |
Timeline
- Start date
- 2021-01-05
- Primary completion
- 2021-02-24
- Completion
- 2021-02-24
- First posted
- 2020-12-31
- Last updated
- 2021-06-18
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04692506. Inclusion in this directory is not an endorsement.